These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8908950

  • 1. The effect of levenogesterol (Norplant) contraception on coagulation as measured by antithrombin-III levels.
    Pryor JA, Cooper KR, Bass JD, Hampton HL, Rock WA, Morrison JC.
    J Miss State Med Assoc; 1996 Oct; 37(10):777-9. PubMed ID: 8908950
    [Abstract] [Full Text] [Related]

  • 2. Subdermal implants in adolescent mothers.
    Contracept Rep; 1995 Jul; 6(3):14. PubMed ID: 12319564
    [Abstract] [Full Text] [Related]

  • 3. Preventing repeat adolescent pregnancies with early adoption of the contraceptive implant.
    Stevens-Simon C, Kelly L, Singer D.
    Fam Plann Perspect; 1999 Jul; 31(2):88-93. PubMed ID: 10224547
    [Abstract] [Full Text] [Related]

  • 4. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
    Shaamash AH, Sayed GH, Hussien MM, Shaaban MM.
    Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
    [Abstract] [Full Text] [Related]

  • 5. Use of Norplant contraceptive implants in the immediate postpartum period: safety and tolerance.
    Phemister DA, Laurent S, Harrison FN.
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):175-9. PubMed ID: 7847530
    [Abstract] [Full Text] [Related]

  • 6. Analysis of weight, packed cell volume changes and menstrual pattern in Norplant implant acceptors in Ilorin, Nigeria.
    Balogun OR.
    Niger J Clin Pract; 2007 Jun; 10(2):116-9. PubMed ID: 17902502
    [Abstract] [Full Text] [Related]

  • 7. Effects of the etonogestrel-releasing contraceptive implant inserted immediately postpartum on maternal hemostasis: a randomized controlled trial.
    Brito MB, Ferriani RA, Meijers JC, Garcia AA, Quintana SM, Silva de Sá MF, Vieira CS.
    Thromb Res; 2012 Sep; 130(3):355-60. PubMed ID: 22542366
    [Abstract] [Full Text] [Related]

  • 8. [Let's talk about Norplant: advances in steroidal contraception].
    Martinez JE.
    Profamilia; 1992 Dec; 8(20):28-34. PubMed ID: 12286384
    [Abstract] [Full Text] [Related]

  • 9. Heparin cofactor II levels are increased by the use of combined oral contraceptives.
    Mackie IJ, Segal H, Burren T, Gallimore M, Walshe KJ, Robinson G, Machin SJ.
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):647-51. PubMed ID: 2133244
    [Abstract] [Full Text] [Related]

  • 10. Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch?
    Thurman AR, Hammond N, Brown HE, Roddy ME.
    J Pediatr Adolesc Gynecol; 2007 Apr; 20(2):61-5. PubMed ID: 17418388
    [Abstract] [Full Text] [Related]

  • 11. Activation of coagulation in smoking and non-smoking women using a third-generation oral contraceptive containing desogestrel.
    Fruzzetti F, De Negri F, Morale M, Ricci C, Ferrini L, Bersi C, Genazzani AR, Carmassi F.
    Eur J Contracept Reprod Health Care; 1999 Sep; 4(3):113-8. PubMed ID: 10574636
    [Abstract] [Full Text] [Related]

  • 12. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Koster T, Bertina RM, Vandenbroucke JP.
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [Abstract] [Full Text] [Related]

  • 13. Patient satisfaction with a levonorgestrel-releasing contraceptive implant. Reasons for and patterns of removal.
    Haugen MM, Evans CB, Kim MH.
    J Reprod Med; 1996 Nov; 41(11):849-54. PubMed ID: 8951137
    [Abstract] [Full Text] [Related]

  • 14. The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1.
    Pakarinen P, Lähteenmäki P, Rutanen EM.
    Acta Obstet Gynecol Scand; 1999 May; 78(5):423-8. PubMed ID: 10326889
    [Abstract] [Full Text] [Related]

  • 15. [Surveillance of women taking oral contraceptives by determination of antithrombin III].
    Benoit MO, Raichvarg D, Caillens H, Neau C.
    Nouv Presse Med; 1979 Feb 10; 8(7):528-9. PubMed ID: 461171
    [Abstract] [Full Text] [Related]

  • 16. [The change of antithrombin III activity of pregnant women and women on oral contraceptives (author's transl)].
    Ogura H, Miyaji K, Kinoshita T, Aoki N.
    Nihon Ketsueki Gakkai Zasshi; 1977 Apr 10; 40(2):232-7. PubMed ID: 578068
    [Abstract] [Full Text] [Related]

  • 17. IMAP statement on Norplant subdermal contraceptive implant system.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP.
    IPPF Med Bull; 1993 Apr 10; 27(2):1-3. PubMed ID: 12345306
    [Abstract] [Full Text] [Related]

  • 18. Effect of etonogestrel subdermal contraceptive implant (Implanon) on liver function tests -- a randomized comparative study with Norplant implants.
    Biswas A, Biswas S, Viegas OA.
    Contraception; 2004 Nov 10; 70(5):379-82. PubMed ID: 15504376
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of some coagulation tests in women using low dosage oral contraception].
    Gramolini R, Perrone G, Calzolari E, Mancone M, Masci A, Materazzi P, Serafini P, Zichella L.
    Patol Clin Ostet Ginecol; 1987 Nov 10; 15(5):307-12. PubMed ID: 12282061
    [Abstract] [Full Text] [Related]

  • 20. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
    Middeldorp S, Meijers JC, van den Ende AE, van Enk A, Bouma BN, Tans G, Rosing J, Prins MH, Büller HR.
    Thromb Haemost; 2000 Jul 10; 84(1):4-8. PubMed ID: 10928461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.